Humana (NYSE: HUM) has announced plans to sell its 40% stake in hospice, palliative and personal care provider Gentiva in a deal valued at approximately $900 million.
Morgan Gonzales is a Reporter at Behavioral Health Business. She specializes in health and wellness, healthcare systems, and the intersection of business and economics within the healthcare sector, covering topics such as patient care, public health, and digital health. Morgan's work has been featured in Daily Voice, RamaOnHealthcare, Hospice News, Behavioral Health Business, and Home Health Care News.












